Leukemia Clinical Trials
Leukemia clinical trials can be outstanding treatment options for certain patients. A clinical trial is a carefully controlled research study through which the effectiveness of a newly discovered treatment is compared to that of treatments currently in widespread use. This evaluation process applies to all new treatments; in fact, even the current “gold standard” leukemia therapies were once available exclusively through clinical trials. If a patient qualifies for and participates in a clinical trial, he or she will have an opportunity to be among the first to benefit from a promising new drug, therapy or technique.
Leukemia clinical trials may be designed to test the effectiveness of exciting new discoveries that show promise in any of a variety of areas, including:
- Diagnosing leukemia in its earliest stages
- Treating various types of leukemia
- Reducing or eliminating treatment side effects
- Preventing leukemia recurrence
- Improving patient outcomes
- Enhancing patient quality of life
A respected leader in cancer research, Moffitt Cancer Center excels at scientific and translational work, and our highly respected scientists are currently investigating all aspects of the condition through our active clinical trial program. Oftentimes, certain treatment agents are available through leukemia clinical trials at Moffitt years before they are made available for widespread use, and we have opportunities for newly diagnosed patients, relapsed patients and transplant patients. At Moffitt, we are firmly committed to taking our promising new discoveries from bench to bedside as soon as possible. In this way, we are continually improving patient outcomes and enhancing quality of life.
To learn about the leukemia clinical trials that are currently underway at Moffitt, call 1-888-663-3488 or complete a new patient registration form online. Our experts can help you determine whether you could potentially benefit from participation in one of our trials. We see patients with and without referrals.